Zinger Key Points
- J M Smucker posts Q3 sales decline of 2% to $2.19 billion.
- J M Smucker cuts FY25 sales growth outlook from 7.50% - 8.50% to 7.25%.
- Get 5 stock picks identified before their biggest breakouts, identified by the same system that spotted Insmed, Sprouts, and Uber before their 20%+ gains.
J M Smucker Co SJM reported third-quarter FY25 sales decline of 2% year-on-year to $2.19 billion, missing the analyst consensus estimate of $2.22 billion.
Gross profit for the quarter increased 7% to $878.1 million and the gross margin expanded 330 basis points to 40.2%.
The company reported an operating loss of $594 million compared to an operating income of $297.4 million.
Adjusted EPS of $2.61 beat the analyst consensus estimate of $2.37. Operating cash flow totaled $239.4 million with a free cash flow was $151.3 million.
Also Read: Mullen EVs Receives Approval For Government And Educational Purchases
The company held $47.2 million in cash and equivalents as of January 31, 2025.
“Net sales for the quarter would have been above our expectations, however, we experienced certain supply chain disruptions that negatively impacted results. Disciplined cost management and execution enabled us to deliver adjusted earnings per share that exceeded our expectations,” said Chair of the Board, President, and CEO Mark Smucker.
Outlook: J M Smucker lowered the FY25 sales growth outlook from 7.50% – 8.50% to 7.25%.
However, the company raised the FY25 adjusted EPS guidance from $9.70 – $10.10 to $9.85 – $10.15.
Capital expenditure for the year is expected to be $400 million – $450 million.
Price Action: SJM shares are trading higher by 0.59% at $109.81 at last check Thursday.
Image via Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.